Lysteda® is the trademark of a synthetically manufactured drug that uses tranexamic acid (1) as an active ingredient , a synthetic amino acid derived from lysine , which belongs to the line of antifibrinolytic drugs with an effect on blood coagulation. blood .
To be highlighted: This pharmaceutical product is manufactured by the company named Mikart Inc. and distributed in Mexico by FERRING, SA de CV . (two)
What is Lysteda used for?
- Thanks to the mechanism of action of its active ingredient, lysteda® reduces the degradation of fibrin by the action of plasmin , resulting in an improvement in blood coagulation and in the reduction of excessive bleeding .
- It is used to treat:
- Heavy cyclical menstrual bleeding. (3)
- Menorrhagia in tooth extractions in patients with hemophilia.
Dosage and routes of administration of lysteda
The lysteda® is sold in tablets with tranexamic acid in a concentration of 650 mg. The administration is orally and the dosage as a reference can be as follows:
- Heavy menstrual bleeding: The established dose in women without kidney failure problems is two 650 mg tablets three times a day for a maximum of 5 days (menstruation period).
Listeda Side Effects
Clinical studies indicate that the use of lysteda® may cause some of the following adverse effects in a certain patient population:
- Possible allergic reactions due to contact with any component of the drug.
- Headache, sinusitis , congestion and sinus pain.
- Skeletal muscle pain.
- Dyspnea, pharyngeal constriction and facial redness.
- Abdominal pain, nausea, dizziness, vomiting , and diarrhea .
- Deep vein thrombosis, pulmonary embolism, cerebral thrombosis, central retinal artery and vein obstruction.
Important: If during treatment with this drug you observe the manifestation of any of these symptoms or others that do not appear on the list, please stop using it and consult your doctor .
Contraindications and warnings of lysteda
The use of lysteda® is contraindicated in the following cases:
- Hypersensitivity of the patient to any of the components of the drug.
- Women using hormonal contraceptives .
- Patients with active thromboembolic disease.
- Patients with intrinsic risk of thrombosis or thromboembolism.
- During the period of pregnancy or breastfeeding .
- In women with problems with the blood vessels in their eyes.
You should know: Provide all the information regarding your health history to your doctor, before starting treatment with lysteda®.
Avoid if you have:
- History of hypersensitivity to tranexamic acid.
- History of cerebrovascular accident
- Recent history of a blood clot.
- History of thrombosis or thromboembolism.
Warnings:
- Pharmaceutical products such as lysteda®, must be administered with a prescription or medical prescription.
- Avoid concomitant use of hormonal contraceptives and this medication.
- Avoid the use of this drug in women receiving treatment with Factor IX concentrates or coagulation inhibitors.
- Caution should be exercised in female patients with leukemia.
- Do not exceed the dose recommended by your doctor and follow his instructions.
- Keep this medicine out of the reach of children.
University Professional in the area of Human Resources, Postgraduate in Occupational Health and Hygiene of the Work Environment, 14 years of experience in the area of health. Interested in topics of Psychology, Occupational Health, and General Medicine.